Poland – Pharmaceutical products – Dostawa leków i wyrobów medycznych
Opportunity Score
Confidence: 30%
Complexity: medium
14 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open tender by Górnośląskie Centrum Medyczne in Katowice, Poland for supply of pharmaceutical products under NFZ drug programs across 3 lots: immunoglobulin, sotatercept, and ravulizumab. Procedure is open, no framework/DPS, no bid bond or security required. Contract duration 12 months with partial deliveries within 5 working days. Estimated value not disclosed. Award based 80% on price and 20% on delivery time. Submission deadline 2026-06-29T10:00:00Z (structured data) or 11:00 CEST (XML notice).
Strengths
Documents available
Open procedure
Medium complexity
Risks
Submission deadline in 14 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Tenderer must hold a pharmaceutical wholesale permit or equivalent authorization to market medicinal products in Poland
- Tenderer may submit offers for up to all 3 lots
- No variants allowed per lot
Buyer
Name
Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach
Location
Katowice, POL
Website
Buyer profile
Identifier
954-22-69-625
Lots (3)
Supply of human normal immunoglobulin under NFZ drug program. Detailed requirements in Annex 2b. Products must be registered, certified, and comply with pharmaceutical laws. Alternatives allowed if pharmaceutically and therapeutically equivalent.
Supply of sotatercept (powder and solvent for injection) under NFZ drug program. Detailed requirements in Annex 2b. Products must be registered, certified, and comply with pharmaceutical laws. Alternatives allowed.
Supply of ravulizumab (concentrate for solution for infusion) under NFZ drug program. Detailed requirements in Annex 2b. Products must be registered, certified, and comply with pharmaceutical laws. Alternatives allowed.
Procurement Details
Publication
27 May 2026
Deadline
29 Jun 2026, 10:00
Procedure
open
Contract
supplies
Duration
12 MONTH
Language
POL
Publication #
363725-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 30%
Complexity: medium
14 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation